期刊文献+

非小细胞肺癌MMP-s和TIMP-s的表达与转移及预后分析 被引量:7

The relationship between the expression of MMPs and TIMPs and metastasis and prognosis in no-small cell lung cancer
下载PDF
导出
摘要 目的检测138例非小细胞肺癌(NSCLC)组织中MMPs及其抑制剂TIMPs蛋白及mRNA水平的表达,探讨其与NSCLC生物学因素的关系。方法运用SP免疫组化技术检测MMP-2、MMP-9、TIMP-1、TIMP-3在138例NSCLC中的表达。RT-PCR检测14例NSCLC中MMP-9、TIMP-3的mRNA表达。结果NSCLC中MMPs和TIMPs的阳性表达率均显著高于正常肺组织及增生及不典型增生上皮,MMPs和TIMPs阳性表达率与TNM分期、淋巴结的转移有关,但与NSCLC分化程度、分类、肿瘤的大小无关;MMP-9、TIMP3的mRNA的表达与淋巴结转移相关;MMP-2的表达与NSCLC患者生存时间呈负相关,而TIMP3表达与生存时间呈正相关。结论MMPs和TIMPs与肺癌的浸润、转移有关,是NSCLC转移、TNM分期、预后的重要指标。 Objective To determine the expressions of MMPs and TIMPs and their eorrelation with biology factors in 138 human non - small eell lung carcinoma (NSCLC) patients at protein and mRNA level. Methods Immunobistochemistry S - P method was used to determine the expressions of MMPs and TIMPs in 138 NSCLC, and deteet the expressions of MMP9 and TIMP3 in 14 NSCLC tissues by RT- PCR. Results The positive expression rates of MMPs and TIMPs in NSCLC were higher signifieantly than normal tissue and hyperplastie or dysplastie epithelium; The positive expression rates of MMPs and TIMPs in NSCLC were associated with TNM stage,lymphatie node metastasis, but without association with eell differentiation of NSCLC and tumor types and tumor size. The expression of mRNA of MMP9 and TIMP3 was associated with lymph node metastasis. Negative eorrelafion was observed between the expression of MMP2 and survival time of NSCLC, but the expression of TIMP3 was positively associated with survival time. Conclusion MMPs and TIMPs are associated with infiltration and metastasis of lung eaneer and thus they are the important indexes for determination of lymph node metastasis, TNM stage and prognosis of lung eaneer.
出处 《中国热带医学》 CAS 2006年第11期1949-1952,共4页 China Tropical Medicine
基金 广东省医学科学技术研究基金资助项目(wstjj20021101440102195511106224)
  • 相关文献

参考文献6

  • 1Delebecq TJ,Porte H,Zerimech F,et al.Overexpression level of stromelysin is related to the lymph node involvement in non-small cell lung cancer[J].Clin Cancer Res,2000,6(3):1086 ~ 10921.
  • 2Gueders MM,Foidart JM,Noel A,et al.Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract:potential implications in asthma and other lung diseases[J].Eur J Pharmacol,2006Mar 8,533(1 ~ 3):133 ~ 144.
  • 3Gomez DE,Alonso DF,Yoshiji H,et al.Tissue inhibitor of metalloproteinases:structure,regulation and biological functions[J].Eur J cell Biol,1997,74(1):111 ~ 122.
  • 4王新允,杨菊红,马莹,郑海燕,程波,郑宏伟,朱丛中.肺癌MMPs和TIMPs的表达及浸润转移的研究[J].中国肺癌杂志,2003,6(4):278-282. 被引量:14
  • 5田东波,肖伟民,曾峰,潘桂常.非小细胞肺癌组织中MMP2及TIMP2的表达与转移、预后相关性研究[J].实用临床医学(江西),2005,6(1):4-7. 被引量:2
  • 6Alabini A,Melchiori A,Santi L,et al.Tumor cell invasion inhibited by TIMP -2[J].J Natl Cancer Inst,1991,83:775 ~ 782.

二级参考文献13

  • 1[1]Albrechtsen R, Wewer UM, Liotta LA. Basement membranes in human cancer. Pathol Annu,1986,21(Pt 2)∶251-276.
  • 2[2]Kawamata H, Kameyama S, Kawai K, et al. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A. Int J Cancer,1995,63(4)∶568-575.
  • 3[4]Urbanski SJ, Edwards DR, Maitland A, et al. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer,1992,66(6)∶1188-1194.
  • 4[5]Hofmann UB, Westphal JR, Van Muijen GN, et al. Matrix metalloproteinases in human melanoma. J Invest Dermatol,2000,115(3)∶337-344.
  • 5[6]Ylisirnio S, Hoyhtya M, Turpeenniemi-Hujanen T. Serum matrix metalloproteinases-2, -9 and tissue inhibitors of metalloproteinases-1, -2 in lung cancer--TIMP-1 as a prognostic marker. Anticancer Res,2000,20(2B)∶1311-1316.
  • 6Tokuraku M, Sato H, Murakami S, et al.Activation of the precursor of gelatinase A/72kDa type IV collagenase/MMP2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase MT-MMP and with lymph node metastasis[J].Int J Cancer, 1995,64:355~359.
  • 7Person SL, Watson SA, Brown PD, et al.Matrix metalloproteinases[J].Br J Surg,1997,84:160~166.
  • 8Hrabec E, Strek M, Nowak D, et al.Elavated level of circulating matrix metalloproteinase-9 in patients with lung cancer[J].J Respiratory Medicine,2001,95:1~4.
  • 9Endo K, Maehara Y, Baba H,et al.Elavated level of serum and plasma metalloproteinases in patients with gastric cancer[J].Anticancer Res,1997,17:2 253~2 258.
  • 10Kleiner D,Stetler-stevenson W.Matrix metalloproteinases and metastasis[J].Cancer Chemother Pharacol, 1999,43(suppl):42~51.

共引文献14

同被引文献70

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部